Americas Cardroom's $15 Million Dual Venoms Reach Day 1D
Venom Fever has awarded 853 seats as the fourth flight begins today.
The opening three flights drew 1,526 NLH entries and 418 PLO entries. A total of 184 NLH players and 51 PLO players have advanced to Day 2, when all remaining players will be in the money and the Mystery Bounty phase begins.
Day 1B produced the largest turnout so far with 1,105 NLH entries and 238 PLO entries. Players can enter the remaining flights, and qualifying stacks may be combined for Day 2.
NLH chip leader eko4gg holds 8,542,202 chips, or 213 big blinds. PLO chip leader Winkyface1984 has 17,037,699 chips, equal to 608 big blinds.
The NLH Venom carries a
Venom Fever has awarded 853 seats worth
Venom Specials have 91 added tournaments and
Flights continue
Full details can be viewed on the Americas Cardroom Blog.
About Americas Cardroom
Americas Cardroom is one of the world's leading online poker destinations, serving players since 2001. Known for major tournament series, innovative promotions, and a commitment to the poker community, the company is celebrating its 25th anniversary in 2026 while continuing to expand its tournament offerings and deliver world-class online poker experiences to players across the globe.
Media Contact:
Adam Neal
Americas Cardroom Pros Manager
Email: [email protected]
Phone: +44 7845 582487
View original content to download multimedia:https://www.prnewswire.com/news-releases/americas-cardrooms-15-million-dual-venoms-reach-day-1d-302856944.html
SOURCE Americas Cardroom
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Signia Introduces MaX, Powered by Acoustic Intelligence™: World's First AI Hearing Aid Platform with 4 DNNs
- New release 'I AM Inner Mastery' offers a roadmap to healing, self-mastery and lasting inner peace
- Skanska to build datacenter near Prague, Czechia, for CZK 2.1 billion, about SEK 930M
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share